FDA: Updated Safety Alert Regarding Benzocaine-Associated Methemoglobinemia

By May 23, 2018

The Agency is urging manufacturers to stop marketing OTC oral drug products containing benzocaine for teething to this patient population.

FDA: Hyland's Teething Tablets Recalled

By April 14, 2017

Laboratory analysis showed that the amount of belladonna in the tablets sometimes exceeded the amount claimed on the product labeling.

FDA: Lab Tests Confirm Inconsistencies in Homeopathic Teething Tablets

By January 27, 2017

The Food and Drug Administration (FDA) announced that the laboratory analysis found inconsistent amounts of belladonna in some homeopathic teething tablets, with levels higher than what is claimed on the label.

Combining Procedures Could Help Limit Anesthesia Exposure in Children

October 26, 2016

Few pediatric patients having a dental procedure combined with another surgical procedure require unplanned admission for perioperative concerns.

FDA: Stop Using Homeopathic Teething Tablets, Gels

By October 03, 2016

After the FDA's safety alert regarding homeopathic teething tablets in 2010, the Agency has been evaluating reported adverse events related to use of these products such as seizures.

Kovanaze Nasal Spray Approved for Dental Anesthesia

August 10, 2016

St. Renatus announced that the Food and Drug Administration (FDA) has approved Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray, the first dental anesthetic administered as a nasal spray.

Baby Teethers May Leach Chemicals From Plastics, Study Suggests

By May 19, 2015

Some plastic teethers for babies may contain endocrine disrupting chemicals, a new study has found.

Oral Viscous Lidocaine Not For Teething Pain, Warns FDA

June 26, 2014

The FDA has issued a warning that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain, and that OTC topical medications may also be harmful and should not be used.

Methemoglobinemia Warning OK'd for Benzocaine Products

May 13, 2014

The FDA announced that it will allow manufacturers of OTC oral health care products containing benzocaine to include a product label warning regarding the risks of methemoglobinemia associated with these products.

Dental Extraction Pre-Cardiac Surgery Can Be Risky

March 03, 2014

For patients with planned dental extraction before cardiac surgery, the risk of a major adverse outcome is 8%, including a 3% risk of death before surgery.

Ob-Gyns Should Discuss Oral Hygiene With All Patients

July 31, 2013

The American College of Obstetricians and Gynecologists (ACOG) recommends that physicians discuss oral health with all patients, including those who are pregnant or postpartum.

FDA Warns of Methemoglobinemia with Benzocaine Topical Products

April 07, 2011

The FDA notified healthcare professionals and patients that it has continued to receive reports of methemoglobinemia associated with benzocaine products.

Hyland's Teething Tablets recalled

October 25, 2010

The FDA has notified consumers of a recall of Hyland's Teething Tablets because the tablets may pose a risk to children.